Israel Ministry of Health Includes INSIGHTEC's Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Services

PR72376

HAIFA, Israel and MIAMI, Feb. 21, 2018 /PRNewswire=KYODO JBN/ --

     INSIGHTEC(R), a commercial-stage medical technology company

revolutionizing surgery with incisionless MR-guided focused ultrasound (MRgFUS)

announced today that the Neuravive focused ultrasound treatment will be a

covered service for essential tremor patients in Israel.

    The Neuravive treatment is a non-invasive solution for patients suffering

from essential tremor who do not respond to medication. During the Neuravive

treatment, focused ultrasound beams are delivered deep in the brain, with no

incisions. The beams converge at the part of the brain responsible for tremor,

heating and destroying the tissue. MRI is used for real-time imaging and

temperature monitoring. The result for many patients is immediate tremor relief.

    "MR-guided Focused Ultrasound is a revolutionary technology with positive

outcomes for essential tremor patients," said Prof. Rafael Beyar MD, General

Director and CEO of Rambam Medical Campus, Israel. "During the last three

years, over sixty patients at Rambam have been treated by a multidisciplinary

team of a neurologist, neurosurgeon, neuro-radiologist and a neurophysiologist

with good results. I am very proud of the global recognition we have received

with this breakthrough technology," he concluded.

    "We are very proud by the Israeli Ministry of Health's decision to include

Neuravive in its list of services covered by public health insurance," said

Prof. Sharon Hassin-Baer,  MD, Neurologist and the Head of the Movement

Disorders Institute at the Sheba Medical Center, in Ramat Gan, Israel. "Now

that the financial barrier has been lifted, a growing number of patients will

have access to this important, restorative, non-invasive treatment."

    "We are excited that Israel is the first national healthcare system to

include the Neuravive treatment in its health services plan and are confident

that the momentum will continue worldwide," said Maurice R. Ferre, MD,

INSIGHTEC's Chief Executive Officer and Chairman of the Board.

    "We are proud that INSIGHTEC was founded in Israel and today employs 200

scientists, engineers and developers at the headquarters in Israel," commented

Eyal Zadicario, INSIGHTEC Chief Operating Officer and General Manager in Israel.

    Essential tremor, a neurological condition, causes uncontrollable shaking

of the hands and may also include shaking of the head, neck or voice. The

tremor can interfere with a person's ability to work and perform daily

activities including writing, dressing and eating.

    The Neuravive treatment is available in Israel at the Rambam Healthcare

Campus in Haifa and Sheba Medical center in Ramat Gan.

    About INSIGHTEC

    INSIGHTEC is the world leader and innovator of MRI-guided Focused

Ultrasound. The company's non-invasive therapy platforms, Exablate and Exablate

Neuro, are proven technology based on sound clinical evidence for treating

essential tremor, painful bone metastases and uterine fibroids. The company is

dedicated to improving patient lives by collaborating with physicians, medical

institutions, academic researchers and regulatory bodies around the world.

INSIGHTEC is headquartered in Haifa, Israel, and Miami, with offices in Dallas,

Tokyo and Shanghai.

    "Exablate," as well as the "INSIGHTEC" logo, whether standing alone or in

connection with the word "INSIGHTEC" are protected trademarks of INSIGHTEC.

    For more information, please visit: www.insightec.com

[http://www.insightec.com ]

Media Contact:

Michelle Barry

Red Lorry Yellow Lorry for INSIGHTEC

insightec@rlyl.com

+1-(857)-217-2886

SOURCE: INSIGHTEC